DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
65.49
+0.24 (0.37%)
At close: Dec 5, 2025, 4:00 PM EST
65.70
+0.21 (0.32%)
After-hours: Dec 5, 2025, 7:02 PM EST

DexCom Market Cap

DexCom has a market cap or net worth of $25.54 billion as of December 5, 2025. Its market cap has decreased by -14.26% in one year.

Market Cap
25.54B
Enterprise Value
24.80B
1-Year Change
-14.26%
Ranking
Category
Stock Price
$65.49

Market Cap Chart

Since April 14, 2005, DexCom's market cap has increased from $312.50M to $25.54B, an increase of 8,073.49%. That is a compound annual growth rate of 23.76%.

History

DateMarket Cap% Change
Dec 4, 202525.45B-16.22%
Dec 31, 202430.38B-36.64%
Dec 29, 202347.95B9.61%
Dec 30, 202243.74B-15.95%
Dec 31, 202152.04B46.58%
Dec 31, 202035.50B77.33%
Dec 31, 201920.02B88.10%
Dec 31, 201810.64B113.41%
Dec 29, 20174.99B-1.16%
Dec 30, 20165.05B-24.21%
Dec 31, 20156.66B57.98%
Dec 31, 20144.21B65.82%
Dec 31, 20132.54B169.96%
Dec 31, 2012941.50M49.75%
Dec 30, 2011628.70M-21.59%
Dec 31, 2010801.80M115.77%
Dec 31, 2009371.60M352.07%
Dec 31, 200882.20M-67.11%
Dec 31, 2007249.90M-9.82%
Dec 29, 2006277.10M-26.81%
Dec 30, 2005378.60M21.15%
View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 908.36B
Johnson & Johnson 487.83B
AbbVie 404.22B
UnitedHealth Group 302.09B
AstraZeneca 279.81B
Novartis AG 255.73B
Merck & Co. 250.41B
Abbott Laboratories 218.05B
Market Cap Rankings